Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haixia Su

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Molecular Nutrition & Food Research|May 12, 2018
Green Tea Liquid Consumption Alters the Human Intestinal and Oral MicrobiomeXiaojie Yuan, Yong Long, Zhaohua Ji, et al.
Carbohydrate Polymers|November 7, 2021
Cocktail polysaccharides isolated from Ecklonia kurome against the SARS-CoV-2 infectionShihai Zhang, Rongjuan Pei, Meixia Li, et al.
European Journal of Medicinal Chemistry|January 26, 2023
Discovery, synthesis and mechanism study of 2,3,5-substituted [1,2,4]-thiadiazoles as covalent inhibitors targeting 3C-Like protease of SARS-CoV-2Pengxuan Ren, Changyue Yu, Ruxue Zhang, et al.
Journal of Medicinal Chemistry|July 29, 2024
Discovery of Novel Nonpeptidic and Noncovalent Small Molecule 3CL<sup>pro</sup> Inhibitors as anti-SARS-CoV-2 Drug CandidateZhidong Jiang, Bo Feng, Lu Chen, et al.
Nature Chemistry|April 27, 2023
Spatiotemporal and global profiling of DNA-protein interactions enables discovery of low-affinity transcription factorsAn-Di Guo, Ke-Nian Yan, Hao Hu, et al.
Journal of Medicinal Chemistry|April 19, 2021
Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2Wenhao Dai, Dirk Jochmans, Hang Xie, et al.
Nature Communications|June 16, 2021
Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL proteaseHaixia Su, Sheng Yao, Wenfeng Zhao, et al.
Nature Communications|October 13, 2023
Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvirXiangrui Jiang, Haixia Su, Weijuan Shang, et al.
Science (New York, N.Y.)|May 3, 2020
Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivirWanchao Yin, Chunyou Mao, Xiaodong Luan, et al.
Journal of Medicinal Chemistry|June 16, 2022
Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure-Activity Relationships, Antiviral Activity, and X-ray Structure DeterminationThanigaimalai Pillaiyar, Philipp Flury, Nadine Krüger, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Molecular Nutrition & Food Research|May 12, 2018
Green Tea Liquid Consumption Alters the Human Intestinal and Oral MicrobiomeXiaojie Yuan, Yong Long, Zhaohua Ji, et al.
Carbohydrate Polymers|November 7, 2021
Cocktail polysaccharides isolated from Ecklonia kurome against the SARS-CoV-2 infectionShihai Zhang, Rongjuan Pei, Meixia Li, et al.
European Journal of Medicinal Chemistry|January 26, 2023
Discovery, synthesis and mechanism study of 2,3,5-substituted [1,2,4]-thiadiazoles as covalent inhibitors targeting 3C-Like protease of SARS-CoV-2Pengxuan Ren, Changyue Yu, Ruxue Zhang, et al.
Journal of Medicinal Chemistry|July 29, 2024
Discovery of Novel Nonpeptidic and Noncovalent Small Molecule 3CL<sup>pro</sup> Inhibitors as anti-SARS-CoV-2 Drug CandidateZhidong Jiang, Bo Feng, Lu Chen, et al.
Nature Chemistry|April 27, 2023
Spatiotemporal and global profiling of DNA-protein interactions enables discovery of low-affinity transcription factorsAn-Di Guo, Ke-Nian Yan, Hao Hu, et al.
Journal of Medicinal Chemistry|April 19, 2021
Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2Wenhao Dai, Dirk Jochmans, Hang Xie, et al.
Nature Communications|June 16, 2021
Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL proteaseHaixia Su, Sheng Yao, Wenfeng Zhao, et al.
Nature Communications|October 13, 2023
Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvirXiangrui Jiang, Haixia Su, Weijuan Shang, et al.
Science (New York, N.Y.)|May 3, 2020
Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivirWanchao Yin, Chunyou Mao, Xiaodong Luan, et al.
Journal of Medicinal Chemistry|June 16, 2022
Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure-Activity Relationships, Antiviral Activity, and X-ray Structure DeterminationThanigaimalai Pillaiyar, Philipp Flury, Nadine Krüger, et al.
Pageof 8